Skip to main content
Erschienen in: Journal of Neurology 10/2014

01.10.2014 | Original Communication

Severe familial paroxysmal exercise-induced dyskinesia

verfasst von: Pawel Tacik, Sebastian Loens, Christoph Schrader, Sabine Gayde-Stephan, Saskia Biskup, Dirk Dressler

Erschienen in: Journal of Neurology | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

Familial paroxysmal exercise-induced dyskinesia (PED) is a rare movement disorder that is mostly caused by mutations in the solute carrier family 2, member 1 (SLC2A1) gene and inherited in an autosomal dominant manner. Clinical, laboratory, and genetic studies were performed in three family members. The proband’s symptoms were recorded in a private video. He was placed on clonazepam. The 42-year-old proband presented with a 34-year-history of “dancing fits” suggesting a psychogenic aetiology. They occurred spontaneously or were triggered by physical exercise with a frequency up to six episodes per month, duration up to 30 min and no impairment of consciousness. Cerebrospinal fluid-(CSF)-to-blood glucose ratio was slightly reduced (0.59) and electroencephalograms were unremarkable. His 63-year-old father had less severe symptoms with spontaneous recovery before age of 45. The proband and his 38-year-old only brother also reported daily absence episodes early in the morning with an onset at age three and spontaneous recovery before age 15. Genetic testing revealed a novel c.972G>A, p.S324S heterozygous variant in the SLC2A1 gene in three patients. No splicing defects at the RNA level could be demonstrated. Five milligrams per day of clonazepam allowed for excellent control of PED. PED may produce a broad range of bizarre movements mimicking psychogenic movement disorders. A positive family history suggests an organic aetiology. PED can effectively be treated with clonazepam. Clinical manifestations, autosomal dominant inheritance and CSF findings suggest a causative role of the SLC2A1 gene, although no splicing defect at the RNA level could be demonstrated for the novel variant. Additional studies such as exome sequencing are indicated.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Weber YG, Storch A, Wuttke TV, Brockmann K, Kempfle J, Maljevic S, Margari L, Kamm C, Schneider SA, Huber SM, Pekrun A, Roebling R, Seebohm G, Koka S, Lang C, Kraft E, Blazevic D, Salvo-Vargas A, Fauler M, Mottaghy FM, Münchau A, Edwards MJ, Presicci A, Margari F, Gasser T, Lang F, Bhatia KP, Lehmann-Horn F, Lerche H (2008) GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 118:2157–2168PubMedCentralPubMed Weber YG, Storch A, Wuttke TV, Brockmann K, Kempfle J, Maljevic S, Margari L, Kamm C, Schneider SA, Huber SM, Pekrun A, Roebling R, Seebohm G, Koka S, Lang C, Kraft E, Blazevic D, Salvo-Vargas A, Fauler M, Mottaghy FM, Münchau A, Edwards MJ, Presicci A, Margari F, Gasser T, Lang F, Bhatia KP, Lehmann-Horn F, Lerche H (2008) GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 118:2157–2168PubMedCentralPubMed
2.
Zurück zum Zitat Demirkiran M, Jankovic J (1995) Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 38:571–579CrossRefPubMed Demirkiran M, Jankovic J (1995) Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 38:571–579CrossRefPubMed
3.
Zurück zum Zitat Groffen AJ, Klapwijk T, van Rootselaar AF, Groen JL, Tijssen MA (2013) Genetic and phenotypic heterogeneity in sporadic and familial forms of paroxysmal dyskinesia. J Neurol 260:93–99PubMedCentralCrossRefPubMed Groffen AJ, Klapwijk T, van Rootselaar AF, Groen JL, Tijssen MA (2013) Genetic and phenotypic heterogeneity in sporadic and familial forms of paroxysmal dyskinesia. J Neurol 260:93–99PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Suls A, Dedeken P, Goffin K, Van Esch H, Dupont P, Cassiman D, Kempfle J, Wuttke TV, Weber Y, Lerche H, Afawi Z, Vandenberghe W, Korczyn AD, Berkovic SF, Ekstein D, Kivity S, Ryvlin P, Claes LR, Deprez L, Maljevic S, Vargas A, Van Dyck T, Goossens D, Del-Favero J, Van Laere K, De Jonghe P, Van Paesschen W (2008) Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 131:1831–1844PubMedCentralCrossRefPubMed Suls A, Dedeken P, Goffin K, Van Esch H, Dupont P, Cassiman D, Kempfle J, Wuttke TV, Weber Y, Lerche H, Afawi Z, Vandenberghe W, Korczyn AD, Berkovic SF, Ekstein D, Kivity S, Ryvlin P, Claes LR, Deprez L, Maljevic S, Vargas A, Van Dyck T, Goossens D, Del-Favero J, Van Laere K, De Jonghe P, Van Paesschen W (2008) Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 131:1831–1844PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Leen WG, Klepper J, Verbeek MM, Leferink M, Hofste T, van Engelen BG, Wevers RA, Arthur T, Bahi-Buisson N, Ballhausen D, Bekhof J, van Bogaert P, Carrilho I, Chabrol B, Champion MP, Coldwell J, Clayton P, Donner E, Evangeliou A, Ebinger F, Farrell K, Forsyth RJ, de Goede CG, Gross S, Grunewald S, Holthausen H, Jayawant S, Lachlan K, Laugel V, Leppig K, Lim MJ, Mancini G, Marina AD, Martorell L, McMenamin J, Meuwissen ME, Mundy H, Nilsson NO, Panzer A, Poll-The BT, Rauscher C, Rouselle CM, Sandvig I, Scheffner T, Sheridan E, Simpson N, Sykora P, Tomlinson R, Trounce J, Webb D, Weschke B, Scheffer H, Willemsen MA (2010) Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 133:655–870CrossRefPubMed Leen WG, Klepper J, Verbeek MM, Leferink M, Hofste T, van Engelen BG, Wevers RA, Arthur T, Bahi-Buisson N, Ballhausen D, Bekhof J, van Bogaert P, Carrilho I, Chabrol B, Champion MP, Coldwell J, Clayton P, Donner E, Evangeliou A, Ebinger F, Farrell K, Forsyth RJ, de Goede CG, Gross S, Grunewald S, Holthausen H, Jayawant S, Lachlan K, Laugel V, Leppig K, Lim MJ, Mancini G, Marina AD, Martorell L, McMenamin J, Meuwissen ME, Mundy H, Nilsson NO, Panzer A, Poll-The BT, Rauscher C, Rouselle CM, Sandvig I, Scheffner T, Sheridan E, Simpson N, Sykora P, Tomlinson R, Trounce J, Webb D, Weschke B, Scheffer H, Willemsen MA (2010) Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 133:655–870CrossRefPubMed
6.
Zurück zum Zitat Bovi T, Fasano A, Juergenson I, Gellera C, Castellotti B, Fontana E, Tinazzi M (2011) Paroxysmal exercise-induced dyskinesia with self-limiting partial epilepsy: a novel GLUT-1 mutation with benign phenotype. Parkinsonism Relat Disord 17:479–481CrossRefPubMed Bovi T, Fasano A, Juergenson I, Gellera C, Castellotti B, Fontana E, Tinazzi M (2011) Paroxysmal exercise-induced dyskinesia with self-limiting partial epilepsy: a novel GLUT-1 mutation with benign phenotype. Parkinsonism Relat Disord 17:479–481CrossRefPubMed
7.
Zurück zum Zitat De Giorgis V, Veggiotti P (2013) GLUT1 deficiency syndrome 2013: current state of the art. Seizure 22:803–811CrossRefPubMed De Giorgis V, Veggiotti P (2013) GLUT1 deficiency syndrome 2013: current state of the art. Seizure 22:803–811CrossRefPubMed
8.
Zurück zum Zitat Leen WG, Taher M, Verbeek MM, Kamsteeg EJ, van de Warrenburg BP, Willemsen MA (2014) GLUT1 deficiency syndrome into adulthood: a follow-up study. J Neurol 261:589–599CrossRefPubMed Leen WG, Taher M, Verbeek MM, Kamsteeg EJ, van de Warrenburg BP, Willemsen MA (2014) GLUT1 deficiency syndrome into adulthood: a follow-up study. J Neurol 261:589–599CrossRefPubMed
9.
Zurück zum Zitat Yang H, Wang D, Engelstad K, Bagay L, Wei Y, Rotstein M, Aggarwal V, Levy B, Ma L, Chung WK, De Vivo DC (2011) Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol 70:996–1005CrossRefPubMed Yang H, Wang D, Engelstad K, Bagay L, Wei Y, Rotstein M, Aggarwal V, Levy B, Ma L, Chung WK, De Vivo DC (2011) Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol 70:996–1005CrossRefPubMed
10.
Zurück zum Zitat Guerrini R, Bonanni P, Nardocci N, Parmeggiani L, Piccirilli M, De Fusco M, Aridon P, Ballabio A, Carrozzo R, Casari G (1999) Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer’s cramp: delineation of the syndrome and gene mapping to chromosome 16p12–11.2. Ann Neurol 45:344–352CrossRefPubMed Guerrini R, Bonanni P, Nardocci N, Parmeggiani L, Piccirilli M, De Fusco M, Aridon P, Ballabio A, Carrozzo R, Casari G (1999) Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer’s cramp: delineation of the syndrome and gene mapping to chromosome 16p12–11.2. Ann Neurol 45:344–352CrossRefPubMed
11.
Zurück zum Zitat Bhatia KP, Soland VL, Bhatt MH, Quinn NP, Marsden CD (1997) Paroxysmal exercise induced dystonia: eight new sporadic cases and a review of the literature. Mov Disord 12:1007–1012CrossRefPubMed Bhatia KP, Soland VL, Bhatt MH, Quinn NP, Marsden CD (1997) Paroxysmal exercise induced dystonia: eight new sporadic cases and a review of the literature. Mov Disord 12:1007–1012CrossRefPubMed
12.
Zurück zum Zitat Dale RC, Melchers A, Fung VS, Grattan-Smith P, Houlden H, Earl J (2010) Familial paroxysmal exercise-induced dystonia: atypical presentation of autosomal dominant GTP-cyclohydrolase 1 deficiency. Dev Med Child Neurol 52:583–586CrossRefPubMed Dale RC, Melchers A, Fung VS, Grattan-Smith P, Houlden H, Earl J (2010) Familial paroxysmal exercise-induced dystonia: atypical presentation of autosomal dominant GTP-cyclohydrolase 1 deficiency. Dev Med Child Neurol 52:583–586CrossRefPubMed
13.
Zurück zum Zitat Baschieri F, Batla A, Erro R, Ganos C, Cordivari C, Bhatia KP (2014) Paroxysmal exercise-induced dystonia due to GLUT1 mutation can be responsive to levodopa: a case report. J Neurol 261:615–616CrossRefPubMed Baschieri F, Batla A, Erro R, Ganos C, Cordivari C, Bhatia KP (2014) Paroxysmal exercise-induced dystonia due to GLUT1 mutation can be responsive to levodopa: a case report. J Neurol 261:615–616CrossRefPubMed
14.
Zurück zum Zitat Anheim M, Maillart E, Vuillaumier-Barrot S, Flamand-Rouvière C, Pineau F, Ewenczyk C, Riant F, Apartis E, Roze E (2011) Excellent response to acetazolamide in a case of paroxysmal dyskinesias due to GLUT1-deficiency. J Neurol 258:316–317CrossRefPubMed Anheim M, Maillart E, Vuillaumier-Barrot S, Flamand-Rouvière C, Pineau F, Ewenczyk C, Riant F, Apartis E, Roze E (2011) Excellent response to acetazolamide in a case of paroxysmal dyskinesias due to GLUT1-deficiency. J Neurol 258:316–317CrossRefPubMed
15.
Zurück zum Zitat Arsov T, Mullen SA, Damiano JA, Lawrence KM, Huh LL, Nolan M, Young H, Thouin A, Dahl HH, Berkovic SF, Crompton DE, Sadleir LG, Scheffer IE (2012) Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia 53:e204–e207CrossRefPubMed Arsov T, Mullen SA, Damiano JA, Lawrence KM, Huh LL, Nolan M, Young H, Thouin A, Dahl HH, Berkovic SF, Crompton DE, Sadleir LG, Scheffer IE (2012) Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia 53:e204–e207CrossRefPubMed
16.
Zurück zum Zitat Mullen SA, Suls A, De Jonghe P, Berkovic SF, Scheffer IE (2010) Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 75:432–440CrossRefPubMed Mullen SA, Suls A, De Jonghe P, Berkovic SF, Scheffer IE (2010) Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 75:432–440CrossRefPubMed
17.
Zurück zum Zitat Schneider SA, Paisan-Ruiz C, Garcia-Gorostiaga I, Quinn NP, Weber YG, Lerche H, Hardy J, Bhatia KP (2009) GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias. Mov Disord 24:1684–1688CrossRefPubMed Schneider SA, Paisan-Ruiz C, Garcia-Gorostiaga I, Quinn NP, Weber YG, Lerche H, Hardy J, Bhatia KP (2009) GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias. Mov Disord 24:1684–1688CrossRefPubMed
18.
Zurück zum Zitat Pong AW, Geary BR, Engelstad KM, Natarajan A, Yang H, De Vivo DC (2012) Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcome. Epilepsia 53:503–510CrossRef Pong AW, Geary BR, Engelstad KM, Natarajan A, Yang H, De Vivo DC (2012) Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcome. Epilepsia 53:503–510CrossRef
19.
Zurück zum Zitat Brockmann K (2009) The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 31:545–552CrossRefPubMed Brockmann K (2009) The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 31:545–552CrossRefPubMed
20.
Zurück zum Zitat Wang D, Pascual JM, Yang H, Engelstad K, Jhung S, Sun RP, De Vivo DC (2005) Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 57:111–118CrossRefPubMed Wang D, Pascual JM, Yang H, Engelstad K, Jhung S, Sun RP, De Vivo DC (2005) Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 57:111–118CrossRefPubMed
21.
Zurück zum Zitat Pons R, Collins A, Rotstein M, Engelstad K, De Vivo DC (2010) The spectrum of movement disorders in Glut-1 deficiency. Mov Disord 25:275–281CrossRefPubMed Pons R, Collins A, Rotstein M, Engelstad K, De Vivo DC (2010) The spectrum of movement disorders in Glut-1 deficiency. Mov Disord 25:275–281CrossRefPubMed
22.
Zurück zum Zitat Afawi Z, Suls A, Ekstein D, Kivity S, Neufeld MY, Oliver K, De Jonghe P, Korczyn AD, Berkovic SF (2010) Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency. Epilepsia 51:2466–2469CrossRefPubMed Afawi Z, Suls A, Ekstein D, Kivity S, Neufeld MY, Oliver K, De Jonghe P, Korczyn AD, Berkovic SF (2010) Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency. Epilepsia 51:2466–2469CrossRefPubMed
23.
Zurück zum Zitat Nguyen AKD, Simard-Meilleur AA, Berthiaume C, Godbout R, Mottron L (2012) Head circumference in Canadian male adults: development of a normalized chart. Int J Morphol 30:1474–1480CrossRef Nguyen AKD, Simard-Meilleur AA, Berthiaume C, Godbout R, Mottron L (2012) Head circumference in Canadian male adults: development of a normalized chart. Int J Morphol 30:1474–1480CrossRef
Metadaten
Titel
Severe familial paroxysmal exercise-induced dyskinesia
verfasst von
Pawel Tacik
Sebastian Loens
Christoph Schrader
Sabine Gayde-Stephan
Saskia Biskup
Dirk Dressler
Publikationsdatum
01.10.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 10/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-014-7441-5

Weitere Artikel der Ausgabe 10/2014

Journal of Neurology 10/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.